| Literature DB >> 30172575 |
Alba Camacho-Cardenosa1, Marta Camacho-Cardenosa2, Darrell Brooks3, Rafael Timón2, Guillermo Olcina2, Javier Brazo-Sayavera4.
Abstract
OBJECTIVE: The aim of the present review is to evaluate effects of intermittent hypoxia and exercise therapy in cardiometabolic parameters on adult obese people. DATABASE: Three well-known databases were selected: EMBASE, MEDLINE and Web of Science. Studies selection: Inclusion criteria were: (a) human healthy overweight or obese adults, (b) study randomized controlled trial, (c) original experimental study, (d) English languages and (e) therapy with intermittent hypoxia and exercise.Entities:
Keywords: Ejercicio; Environmental physiology; Exercise; Fisiología; Hipoxia y mujer; Hypoxia and women; Obesidad; Obesity
Year: 2018 PMID: 30172575 PMCID: PMC6837087 DOI: 10.1016/j.aprim.2018.03.011
Source DB: PubMed Journal: Aten Primaria ISSN: 0212-6567 Impact factor: 1.137
Sample characteristics, design and outcomes measures of the included studies.
| Ref | Sample size ( | Age (mean ± SD) | Group | Design | Hypoxia treatment | Exercise treatment | Outcome (level of evidence) | Report effect |
|---|---|---|---|---|---|---|---|---|
| 32* | 52.4 ± 7.9 | Hypoxia group | 26 weeks | 90’; FiO2 = 14.0+ | 90’ (65–70% HRmax) | Weight (2) | Δ# | |
| 50.3 ± 10.3 | Control group | Sea level | 90’ (65–70% HRmax) | |||||
| 22* | 22.3 ± 1.7 | Normoxia training | 4 weeks | Sea level | 120’ (60–70%HRmax) | Weight (2) | # ↑ | |
| 19.8 ± 2.2 | Hypoxia training | 4 weeks | 8 sessions (sea level) | 120’ (60–70%HRmax) | ||||
| 32* | 29 ± 2 | Lean Group | 1 session | Hypoxia: FiO2 = 10% | Resting | Total blood pressure (3) | Δ # ↑MS | |
| 24 ± 2 | Obese group | Hypoxia: FiO2 = 10% | Resting | Ventilation (3) | Δ # ↑MS | |||
| 29 ± 3 | MS group | Hypoxia: FiO2 = 10% | ||||||
| 20* | 50.1 ± NR | Hypoxia training | 8 weeks | FiO2 = 15.0% | 90’ (60% VO2max) | Weight (2) | ↑ | |
| 45.5 ± NR | Sham hypoxia training | FiO2 = 20.9% | ||||||
| 45* | 42 ± 7.1 | Hypoxia group | 4 weeks | FiO2 = 15.0% | 60’ (60% VO2max) | Weight (2) | = | |
| Control group | FiO2 = 20.9% |
CG: control group; EG: experimental group; NR: not reported; MS: metabolic syndrome; Ob: obese; *: n for treatment effects analysis.
=: no significant difference relative to baseline and/or the control group; ↑: statistically significant improvements in the experimental group relative to the control group; ↓: statistically significant deterioration in the experimental group relative to the control group; Δ: statistically significant improvements in the experimental group; #: statistically significant improvements in the control group.